Magnetization Transfer Quantitation and Characterization for Clinical Scanners
NCT00001714 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2008-03-04
Summary
This project will measure magnetization transfer (MT) parameters on normal subjects using two novel approaches. The first is the investigation of asymmetric MT effects with respect to the zero or on-resonance reference point. The technique measures the difference in MT effect between two symmetrically positioned off-resonance MT pulses in the positive and negative frequency ranges. Prior research with this technique in the kidney show a difference in the macromolecular lineshape that correlates to a specific metabolite. The second approach, utilizing a subset of the acquisitions from the first approach, will test newly developed formulation to calculate the macromolecular fraction, or fraction of proton density that accounts for MT. We foresee these measurements may significantly develop our understanding of MT and introduce diagnostic and quantitative tools to study human tissues.
Conditions
- Healthy
Sponsors & Collaborators
-
National Institutes of Health Clinical Center (CC)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1998-03-31
- Completion
- 2001-07-31
Countries
- United States
Study Locations
More Related Trials
-
Study of New Magnetic Resonance Imaging Methods of the Brain
NCT00004577 ·Status: RECRUITING
-
Clinical Testing of New MR Pulse Sequences
NCT00590252 ·Status: UNKNOWN
-
Development of Novel MR Techniques Using Volunteer Participants
NCT05943249 ·Status: RECRUITING
-
Ultrahigh Field Body MR Imaging
NCT02236143 ·Status: ENROLLING_BY_INVITATION
-
Low Field Magnetic Resonance Imaging Assessment With Outpatients
NCT05582785 ·Status: RECRUITING ·Phase: NA
-
Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.
NCT00184353 ·Status: COMPLETED
-
Evaluation of Patient Comfort and Image Quality in Magnetic Resonance Imaging
NCT02726594 ·Status: UNKNOWN
-
Renal Functional Magnetic Resonance Imaging in Healthy Persons - Reproducibility and Impact of Stress
NCT04656314 ·Status: COMPLETED
-
Natural History of Multiple Sclerosis and Its Mimickers
NCT02504840 ·Status: COMPLETED
-
Development of Protocols and Methods for Image Processing and Enhancement of Magnetic Resonance Imaging (MRI) Data.
NCT04942704 ·Status: UNKNOWN
-
Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome
NCT01737255 ·Status: COMPLETED
-
Development of Techniques for Use in MRI With a Magnetic Field of 7 Tesla
NCT00056914 ·Status: COMPLETED
-
Development and Evaluation of Magnetic Resonance Imaging Acquisition and Analysis Methods
NCT02091518 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Evaluation of New Magnetic Resonance Techniques
NCT05118555 ·Status: RECRUITING
-
New Ways of Doing Magnetic Resonance Imaging in Children and Adults
NCT04643015 ·Status: ACTIVE_NOT_RECRUITING
-
Imaging of Traumatic Brain Injury
NCT01196299 ·Status: COMPLETED
-
Clinical Evaluation of an Integrated PET/MRI System
NCT02071706 ·Status: COMPLETED ·Phase: NA
-
[18F]NIDF PET Imaging in Tau-related Diseases
NCT07306598 ·Status: RECRUITING
-
Comparative Study of Conventional MR Images With Synthetically Reconstructed MR Images of the Brain
NCT05425927 ·Status: COMPLETED ·Phase: NA
-
Use of PET/MR Imaging in Chronic Pain
NCT03195270 ·Status: COMPLETED ·Phase: PHASE1
-
Changes in the MRI Signal in Patients With Benign Tumors of the Brain and Meninges Treated With Proton Therapy: Impact of TEL and the Biological Dose Received
NCT04584086 ·Status: COMPLETED ·Phase: NA
-
Variability of Cerebral MRI Diffusion Parameters by Using a Patented Normalization Process vs no Use
NCT05446922 ·Status: UNKNOWN ·Phase: NA
-
Investigation of GM Pathology Using Ultra High Field (7T) MRI Scanner
NCT01805986 ·Status: UNKNOWN
-
Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy
NCT01045044 ·Status: WITHDRAWN
-
BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
NCT00887601 ·Status: COMPLETED ·Phase: PHASE1